Deoxycholic acid-grafted PEGylated chitosan micelles for the delivery of mitomycin C

Drug Development and Industrial Pharmacy

Volumn 41, Issue 6, 2015, Pages 916-926

  Zhang, Xiu Rong ^a   Shi, Nian Qiu ^a   Zhao, Yang ^a   Zhu, He Yun ^a   Guan, Jiao ^a   Jin, Ying ^a  

^a JILIN MEDICAL COLLEGE   (China)

Author keywords

Biodistribution; Mitomycin C; Pharmacokinetics; Polymeric micelles; Synthesis

Indexed keywords

CHITOSAN; DEOXYCHOLIC ACID; MACROGOL; MITOMYCIN; NANOPARTICLE; POLY(ETHYLENE GLYCOL) METHYL ETHER; UNCLASSIFIED DRUG; ANTINEOPLASTIC ANTIBIOTIC; DRUG CARRIER; MACROGOL DERIVATIVE; MICELLE; MONOMETHOXYPOLYETHYLENE GLYCOL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; CRITICAL MICELLE CONCENTRATION; DRUG BIOAVAILABILITY; DRUG CLEARANCE; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG DOSAGE FORM COMPARISON; DRUG RELEASE; DRUG SAFETY; DRUG TISSUE LEVEL; ELIMINATION HALF-LIFE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYDRODYNAMICS; INFRARED SPECTROSCOPY; MALE; MASS SPECTROMETRY; MAXIMUM PLASMA CONCENTRATION; MEAN RESIDENCE TIME; MICELLE; MORPHOLOGY; NANOENCAPSULATION; NANOMICELLE; NONHUMAN; PARTICLE SIZE; PHYSICAL CHEMISTRY; PLASMA CONCENTRATION-TIME CURVE; PROTON NUCLEAR MAGNETIC RESONANCE; RAT; SYNTHESIS; TISSUE DISTRIBUTION; ZETA POTENTIAL; ANIMAL; BIOAVAILABILITY; CHEMISTRY; COMPARATIVE STUDY; DRUG FORMULATION; MEDICINAL CHEMISTRY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PROCEDURES; WISTAR RAT;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; AREA UNDER CURVE; BIOLOGICAL AVAILABILITY; CHEMISTRY, PHARMACEUTICAL; CHITOSAN; DEOXYCHOLIC ACID; DRUG CARRIERS; DRUG COMPOUNDING; DRUG DELIVERY SYSTEMS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MICELLES; MITOMYCIN; PARTICLE SIZE; POLYETHYLENE GLYCOLS; RATS; RATS, WISTAR; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; TISSUE DISTRIBUTION;

EID: 84930508592     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.3109/03639045.2014.913613     Document Type: Article

References (41)

1. Gaucher G, Dufresne MH, Sant VP, et al. Block copolymer micelles: preparation, characterization and application in drug delivery. J Control Release 2005;109:169-88.
2. Haque S, Md S, Alam MI, et al. Nanostructure-based drug delivery systems for brain targeting. Drug Dev Ind Pharm 2012;38:387-411.
3. Liang H, Yang Q, Deng L, et al. Phospholipid-Tween 80 mixed micelles as an intravenous delivery carrier for paclitaxel. Drug Dev Ind Pharm 2011;37:597-605.
4. Mahmud A, Xiong XB, Aliabadi HM, Lavasanifar A. Polymeric micelles for drug targeting. J Drug Target 2007;15:553-84.
5. Kataoka K, Harada A, Nagasaki Y. Block copolymer micelles for drug delivery: design, characterization and biological significance. Adv Drug Deliv Rev 2001;47:113-31.
6. Torchilin VP. Micellar nanocarriers: pharmaceutical perspectives. Pharm Res 2007;24:1-16.
7. Zhao Y, Li Y, Ge J, et al. Pluronic-poly (acrylic acid)-cysteine/pluronic L121 mixed micelles improve the oral bioavailability of paclitaxel. Drug Dev Ind Pharm 2013. [Epub ahead of print].
8. Hong JW, Park JH, Huh KM, et al. PEGylated polyethylenimine for in vivo local gene delivery based on lipiodolized emulsion system. J Control Rel 2004;99:167-76.
9. Wang Y, Ke CY, Weijie Beh C, et al. The self-assembly of biodegradable cationic polymer micelles as vectors for gene transfection. Biomaterials 2007;28:5358-68.
10. Oikawa Y, Lee S, Kim do H, et al. One-pot synthesis of linearhyperbranched amphiphilic block copolymers based on polyglycerol derivatives and their micelles. Biomacromolecules 2013;14:2171-8.
11. Ouahab A, Shao C, Shen Y, Tu J. Development and characterization of stabilized double loaded mPEG-PDLLA micelles for simultaneous delivery of paclitaxel and docetaxel. Drug Dev Ind Pharm 2013. [Epub ahead of print]. doi:10.3109/03639045.2013.788017.
12. Nasongkla N, Bey E, Ren J, et al. Multifunctional polymeric micelles as cancer-targeted, MRI-ultrasensitive drug delivery systems. Nano Lett 2006;6:2427-30.
13. Francis MF, Cristea M, Yang Y, Winnik FM. Engineering polysaccharide-based polymeric micelles to enhance permeability of cyclosporin A across Caco-2 cells. Pharmaceut Res 2005;22: 209-19.
14. Hassani LN, Hendra F, & Bouchemal K. Auto-associative amphiphilic polysaccharides as drug delivery systems. Drug Discov Today 2012;17:608-14.
15. Kumar MN, Muzzarelli RA, Muzzarelli C, et al. Chitosan chemistry and pharmaceutical perspectives. Chem Rev 2004;104:6017-84.
16. Lee CM, Park JW, Kim J, et al. Influence of histidine on the release of all-trans retinoic acid from self-assembled glycol chitosan nanoparticles. Drug Dev Ind Pharm 2010;36:781-6.
17. Zhang J, Xia W, Liu P, et al. Chitosan modification and pharmaceutical/biomedical applications. Mar Drugs 2010;8:1962-87.
18. Liu X, Ma L, Mao Z, Gao C. Chitosan-based biomaterials for tissue repair and regeneration. Adv Polymer Sci 2011;244:81-128.
19. Veronese FM, Pasut G. PEGylation, successful approach to drug delivery. Drug Discov Today 2005;10:1451-8.
20. Ryan SM, Mantovani G, Wang X, et al. Advances in PEGylation of important biotech molecules: delivery aspects. Expert Opin Drug Deliv 2008;5:371-83.
21. Harris JM, Chess RB. Effect of pegylation on pharmaceuticals. Nat Rev Drug Discov 2003;2:214-21.
22. Bailon P, Won CY. PEG-modified biopharmaceuticals. Expert Opini Drug Deliv 2009;6:1-16.
23. Veronese FM, Mero A. The impact of PEGylation on biological therapies. BioDrugs 2008;22:315-29.
24. Pasut G, Veronese FM. PEG conjugates in clinical development or use as anticancer agents: an overview. Adv Drug Deliv Rev 2009;61: 1177-88.
25. Yue-Jian C, Juan T, Fei X, et al. Synthesis, self-assembly, and characterization of PEG-coated iron oxide nanoparticles as potential MRI contrast agent. Drug Dev Ind Pharm 2010;36:1235-44.
26. Roberts MJ, Bentley MD, Harris JM. Chemistry for peptide and protein PEGylation. Adv Drug Deliv Rev 2002;54:459-76.
27. Opanasopit P, Ngawhirunpat T, Rojanarata T, et al. Camptothecinincorporating N-phthaloylchitosan-g-mPEG self-assembly micellar system: effect of degree of deacetylation. Colloids Surf B Biointerfaces 2007;60:117-24.
28. Sezgin Z, Yüksel N, Baykara T. Preparation and characterization of polymeric micelles for solubilization of poorly soluble anticancer drugs. Eur J Pharm Biopharm 2006;64:261-8.
29. Opanasopit P, Yokoyama M, Watanabe M, et al. Block copolymer design for camptothecin incorporation into polymeric micelles for passive tumor targeting. Pharm Res 2004;21:2001-8.
30. Li SD, Huang L. Pharmacokinetics and biodistribution of nanoparticles. Mol Pharm 2008;5:496-504.
31. Zhou JC, Zhuang DQ, Yuan XF, et al. Association of fluorocarbon and hydrocarbon end-capped poly(ethylene glycol)s: 1H-NMR and fluorescence studies. Langmuir 2000;16:9653-61.
32. Rasmussen JW, Martinez E, Louka P, Wingett DG. Zinc oxide nanoparticles for selective destruction of tumor cells and potential for drug delivery applications. Expert Opin Drug Deliv 2010;7: 1063-77.
33. Cho K, Wang X, Nie S, et al. Therapeutic nanoparticles for drug delivery in cancer. Clinical Cancer Res 2008;14:1310-16.
34. Kwon S, Park JH, Chung H, et al. Physicochemical characteristics of self-assembled nanoparticles based on glycol chitosan bearing 5-cholanic acid. Langmuir 2003;19:10188-93.
35. Huo M, Zou A, Yao C, et al. Somatostatin receptor-mediated tumortargeting drug delivery using octreotide-PEG-deoxycholic acid conjugate-modified N-deoxycholic acid-O, N-hydroxyethylation chitosan micelles. Biomaterials 2012;33:6393-407.
36. Mu CF, Balakrishnan P, Cui FD, et al. The effects of mixed MPEG-PLA/pluronic copolymer micelles on the bioavailability and multidrug resistance of docetaxel. Biomaterials 2010;31: 2371-9.
37. Tong SW, Xiang B, Dong DW, Qi XR. Enhanced antitumor efficacy and decreased toxicity by self-associated docetaxel in phospholipidbased micelles. Int J Pharm 2012;434:413-19.
38. Rauth AM, Mohindra JK, Tannock IF. Activity of mitomycin C for aerobic and hypoxic cells in vitro and in vivo. Cancer Res 1983;43: 4154-8.
39. Rockwell S, Hughes CS. Effects of mitomycin C and porfiromycin on exponentiallygrowing and plateau phase cultures. Cell Prolif 1994;27:153-63.
40. Cheung RY, Ying Y, Rauth AM, et al. Biodegradable dextran-based microspheres for delivery of anticancer drug mitomycin C. Biomaterials 2005;26:5375-85.
41. Hou Z, Li Y, Huang Y, et al. Phytosomes loaded with mitomycin C-soybean phosphatidylcholine complex developed for drug delivery. Mol Pharm 2013;10:90-101.